Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics

Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics

Gene replacement therapy with oncosuppressor microRNAs (miRNAs) is a promising alternative to interfere with cancer progression. However, miRNAs are highly inefficient in a biological environment, hampering a successful translation to clinics. Nanotechnology can tackle this drawback by providing del...

Full description

Bibliographic Details
Main Authors: Surasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, Maria de la Fuente
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Pharmaceutics
Subjects:
sphingomyelin
nanomedicine
gene therapy
oncosuppressor mirnas
colorectal cancer
Online Access:https://www.mdpi.com/1999-4923/12/2/189

Internet

https://www.mdpi.com/1999-4923/12/2/189

Similar Items